Humatech Stock

Humatech Shares Outstanding

The The number of shares of Humatech (HUMT) as of Sep 9, 2026 is 34.28 M.

Shares Outstanding

34.28 M

Last updated:

In 2026, Humatech had 34.28 M outstanding stocks, a % change from the - stocks in the previous year.

The Humatech Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2001
9.57 USD
Jan 1, 2002
13.01 USD
Jan 1, 2003
16.52 USD
Jan 1, 2004
23.02 USD
Jan 1, 2005
31.91 USD
Jan 1, 2006
34.28 M USD
The Humatech Shares Outstanding history
YEARShares OutstandingYoY
34.28 M+107.40 M%
31.91+38.66%
23.02+39.33%
16.52+26.96%
13.01+36.01%
9.57
Access this data via the Eulerpool API

Humatech Number of shares

Humatech shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2001
9.57 M Stocks
Jan 1, 2002
13.01 M Stocks
Jan 1, 2003
16.52 M Stocks
Jan 1, 2004
23.02 M Stocks
Jan 1, 2005
31.91 M Stocks
Jan 1, 2006
34.28 M Stocks

Humatech Stock analysis

What does Humatech do? Humatech Inc is an international company that specializes in the development, production, and marketing of products for the healthcare industry. The company was founded in 1983 and has since adapted its business models and strategies to meet the changing demands of the market. It is now headquartered in Virginia, USA and operates on multiple continents. The business model of Humatech Inc focuses on the manufacturing of diagnostic and testing products for laboratory and clinical facilities. These products are designed for the diagnosis of diseases such as cancer, diabetes, pregnancy, thyroid problems, and many others. The company also offers HIV, hepatitis, and troponin tests. The high quality of these products has helped the company establish strong brand recognition and customer loyalty. In addition to its products, Humatech Inc also provides services in various areas to offer comprehensive solutions tailored to individual needs. These services include consulting, software solutions, and training, contributing to optimized and efficient operations in medical facilities and laboratories. The different divisions of Humatech Inc encompass a wide range of products and services. The category of diagnostic and testing products forms the core of the company, including tests for diabetes, pregnancy, thyroid problems, cancer, HIV, and hepatitis. The range also includes specialized tests for kidney problems and heart diseases. The company is constantly striving to expand its range of tests for new health issues. Under the category of consulting services, Humatech Inc offers in-depth knowledge of current medical developments, diagnostic procedures, and testing methods. Customers can choose from a wide range of services, including the development of specific test procedures, marketing support, and workflow optimization. The "software solutions" business field includes a variety of online tools to support diagnostic procedures and tests. The software allows medical facilities and laboratories to automate their workflow, manage and analyze data, and quickly retrieve test results. To provide customers with added value, Humatech Inc also offers a range of training programs. These not only cover the operation and application of the products, but also teach optimal work and result processes. Overall, Humatech Inc is an important player in the healthcare industry. By focusing on the development and marketing of diagnostic and testing products, the company is able to sustainably convince its customers through high product quality and services. The wide product range, services, and extensive network of employees, consultants, and customers make the company a forward-thinking service provider. Humatech is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Humatech's Shares Outstanding

Humatech's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Humatech’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Humatech’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Humatech’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Humatech stock

The number of shares of Humatech is 34.28 M in 2026.

On Eulerpool you can find the complete historical development of The number of shares Humatech since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

Other — Humatech

All Key Metrics — Humatech